Skip to content

DIH Holding US, Inc. Warrants (DHAIW) Company Overview

Company Analysis

DIH Holding US, Inc. Warrants DHAIW

A comprehensive view of key metrics, scores, and financial health for DIH Holding US, Inc. Warrants

Overview of DIH Holding US, Inc.

DHAIW NGM
DIH Holding US, Inc. (DHAIW), in the Medical Devices industry, last closed at $0.00, about 0.0% overvalued vs fair value, ranked 980/1122 in sector.
USD 0.00
0.00%
(Delayed)
Enterprise Value
-
Overall Score
Overall
Growth
Weak
Profitability
Good
Health
Weak
Efficiency
Weak
Growth
Weak
Profitability
Good
Health
Weak
Efficiency
Weak
Completeness: 56%
Confidence: 36%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

HQ Norwell, MA
Employees 178
Fiscal year Mar 31

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Shares outstanding missing or non-positive

Engine Room Money Flow™

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$64.5M
17.2%%
Gross Profit
$29.8M
-13.8%%
Operating Income (GAAP)
$-2.6M
-1099.1%%
EBITDA
$-6.2M
-1051.2%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
46.2%
Fair

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$153.2M
3070.1% of Free Cash Flow

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
1
Active Leaks
1/1
Improving
0
High Impact
1
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating DIH Holding US, Inc. Warrants's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
57
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
34
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 78% Coverage
Trade-Off Triangle Visualization A ternary plot showing DHAIW's balance between Growth (21.9%), Profitability (42.1%), and Safety (36.0%). Growth 22% Safety 36% Profitability 42%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

- vs peers
-
Key Signals
Rev Growth YoY 17.2% 72p Asset Growth YoY -4.5% 42p
  • ROIC in top 20% of peers (9.8%, 86th percentile)
  • Net Debt/EBITDA in top 20% of peers (19.39, 95th percentile)
  • Superior capital returns - 2 return metrics above peer median
  • Consistently strong margins across 3 metrics
  • Growth axis has low metric coverage (35%) - score may be unreliable

Profitability

64th percentile vs peers
64
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

54th percentile vs peers
55
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for DIH Holding US, Inc. Warrants.

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000